Verified call record已核验电话会记录 · 2026-05-06

TARS · Tarsus Pharmaceuticals Inc Q1 FY2026 earnings call record财报电话会记录

Verbatim, receipt-bound excerpts from the earnings-call transcript. This is a source record, not a synthesized analysis or recommendation.来自财报电话会文字记录的原文、可追溯摘录。这是来源记录，不是综合分析或推荐。

Open ticker dossier打开个股档案TARS

12 exact excerpts 条原文摘录 28 numeric receipts 个数值回执 B governed source tier 治理来源层级 Transcript present电话会文本已具备

The record记录内容

Call language, kept intact.电话会表述，保持原貌。

The excerpts below are selected from the source record under the bounded evidence policy. Wording is not paraphrased; numbers remain the exact spans captured from the call.以下摘录按受限证据策略从来源记录中选出。文字未被改写；数字保持电话会中捕获的精确片段。

guidanceperformancemarginsq_and_a

“Looking ahead, we reiterate our full year 2026 guidance of net product sales of $670 million-$700 million, SG&A expenses of $545 million-$565 million, including approximately $40 million in stock-based compensation, R&D expenses of $115 million-$135 million, including stock-based compensation of approximately $20 million, and gross margins of approximately 93%.”

Jeff Farrow · CFOclaim_15d4926a42f0a4a00cb1671e18d5602f

Exact numeric spans精确数值片段2026670 million700 million545 million565 million40 million115 million135 million20 million93

guidanceperformanceq_and_a

“These are the same drivers we have committed to delivering on, and we are on track to achieve our full-year guidance, reach blockbuster status in the next couple of years, and realize $2 billion in peak sales potential.”

Bobby Azamian · CEOclaim_1188cd05af13bb33bcd8ee1ff64d997b

Exact numeric spans精确数值片段2 billion

Member evidence layer会员证据层

10 more verified excerpts continue below.条更多已核验摘录在下方继续。

You have the public source preview. Essential and Pro unlock the complete call record, every remaining numeric receipt, and the full audit table—without replacing source language with generated opinion.你正在阅读公开来源预览。Essential 与 Pro 可解锁完整电话会记录、全部剩余数值回执和完整审计表——不会用生成式观点替代来源原文。

Unlock full company intelligence解锁完整公司情报

2 public excerpts 条公开摘录10 member excerpts 条会员摘录28 total numeric receipts 个数值回执

Inspect the source receipts检查来源回执40 bound spans个已绑定片段

Each available row identifies the source body, transcript segment and byte span used to verify the visible text.每个可用行都标识用于核验可见文本的来源正文、电话会片段和字节范围。

Claim主张	Kind类型	Segment片段	Byte span字节范围	Text hash文本哈希
`claim_1188cd05af13bb33bcd8ee1ff64d997b`	quote	2	470–689	`02cff3fc91d5a9…`
`claim_dfff874b4c3192317cfea3ac4bc38080`	numeric	2	655–664	`ea31cc727265d3…`
`claim_15d4926a42f0a4a00cb1671e18d5602f`	quote	16	325–688	`2d265a273d56b5…`
`claim_f260e413ea4e509ddf5c88cc6359fe80`	numeric	16	367–371	`158a323a7ba448…`
`claim_b9b3408568cb665e8890b96f0a019151`	numeric	16	406–417	`b6ff4eb0516b36…`
`claim_7033f347f7a0d2006e5c5d9af7dd4af7`	numeric	16	419–430	`411b9f2b384f08…`
`claim_a953dc9915352b62d64916139816eac0`	numeric	16	450–461	`6d2fdc36b5ce1e…`
`claim_135867132bedebd10298caff8479edcc`	numeric	16	463–474	`a8075608e06a1c…`
`claim_9691543a24b80c4b1b3d146650793a99`	numeric	16	501–511	`848b0a1916da2f…`
`claim_8bc295626017441f586bf7d9d2fdbc29`	numeric	16	558–569	`3ccb081db90490…`
`claim_e91fd441c03695e7d67d5f2274ec8eea`	numeric	16	571–582	`daf33a65b11232…`
`claim_b85acd244e56b02a0049b77455a1e855`	numeric	16	637–647	`fc8e4edca5588c…`
`claim_ed068e67c86706753f79583e228ece3d`	numeric	16	684–686	`6e4001871c0cf2…`